Top

Reactions Weekly

Published in:

01-05-2023 | Metastasis | Case report

Antineoplastics/iodine-radioactive

Lack of efficacy and various toxicities: 4 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Baek H-S, et al. Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea. Current Oncology 30: 3020-3031, No. 3, Mar 2023. Available from: URL: http://doi.org/10.3390/curroncol30030229

Title: Antineoplastics/iodine-radioactive
Lack of efficacy and various toxicities: 4 case reports
Publication date: 01-05-2023
Publisher: Springer International Publishing
Keywords: Metastasis
Thyroidectomy
Thyroidectomy
Lenvatinib
Vandetanib
Thyroid Cancer
Thyroid Cancer
Thyroid Cancer
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-38301-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastics/iodine-radioactive

Lack of efficacy and various toxicities: 4 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Brigatinib

Citalopram/quetiapine/venlafaxine

Daratumumab/dexamethasone/lenalidomide

Multiple drugs

Multiple drugs

Isoniazid/pyrazinamide/rifampicin